Advertisement

Topics

Cambrex invests in highly potent API manufacturing facility

08:26 EDT 10 Aug 2017 | EPM Magazine

Cambrex, a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), is investing $24 million in a new highly potent API manufacturing facility in Charles City, Iowa.

Original Article: Cambrex invests in highly potent API manufacturing facility

NEXT ARTICLE

More From BioPortfolio on "Cambrex invests in highly potent API manufacturing facility"

Quick Search
Advertisement
 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...